These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18596080)

  • 1. Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition.
    Stoessel A; Paliege A; Theilig F; Addabbo F; Ratliff B; Waschke J; Patschan D; Goligorsky MS; Bachmann S
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F717-25. PubMed ID: 18596080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach.
    Addabbo F; Ratliff B; Park HC; Kuo MC; Ungvari Z; Csiszar A; Krasnikov B; Sodhi K; Zhang F; Nasjletti A; Goligorsky MS
    Am J Pathol; 2009 Jan; 174(1):34-43. PubMed ID: 19095954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C; Leuschner S; Schwanebeck U; Kirch W
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic NOS inhibition actuates endothelial-mesenchymal transformation.
    O'Riordan E; Mendelev N; Patschan S; Patschan D; Eskander J; Cohen-Gould L; Chander P; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H285-94. PubMed ID: 16963618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
    Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
    Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery.
    Overend J; Martin W
    Br J Pharmacol; 2007 Feb; 150(4):488-93. PubMed ID: 17211453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
    Adeagbo AS; Triggle CR
    Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function.
    Cardounel AJ; Cui H; Samouilov A; Johnson W; Kearns P; Tsai AL; Berka V; Zweier JL
    J Biol Chem; 2007 Jan; 282(2):879-87. PubMed ID: 17082183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG-monomethyl-L-arginine increases platelet deposition on damaged endothelium in vivo. A scanning electron microscopic study.
    Herbaczyńska-Cedro K; Lembowicz K; Pytel B
    Thromb Res; 1991 Oct; 64(1):1-9. PubMed ID: 1723225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
    Thiemermann C; Ruetten H; Wu CC; Vane JR
    Br J Pharmacol; 1995 Dec; 116(7):2845-51. PubMed ID: 8680715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
    Liu X; Xu X; Shang R; Chen Y
    Nitric Oxide; 2018 Aug; 78():113-120. PubMed ID: 29928990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid non-genomic effects of aldosterone on the renal vasculature.
    Schmidt BM
    Steroids; 2008 Oct; 73(9-10):961-5. PubMed ID: 18242654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia.
    Wang Y; Gu Y; Zhang Y; Lewis DF
    Am J Obstet Gynecol; 2004 Mar; 190(3):817-24. PubMed ID: 15042020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of nitric oxide synthase modulation on porcine systemic and pulmonary circulation in vivo.
    Dahm P; Thörne J; Zoucas E; Mårtensson L; Myhre E; Blomquist S
    Crit Care Med; 1997 Feb; 25(2):280-5. PubMed ID: 9034265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.
    Radomski MW; Vallance P; Whitley G; Foxwell N; Moncada S
    Cardiovasc Res; 1993 Jul; 27(7):1380-2. PubMed ID: 7504587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.